Clinical trialNCT06533553Active, not recruitingPhase 2Interventional

A Study to Assess the Effects of Dexpramipexole in Participants With Eosinophilic COPD

SponsorAreteia TherapeuticsEnrollment30Chronic Obstructive Pulmonary Disease

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Gerard J Criner, MD
Temple University
Principal InvestigatorKOL profile →
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

23 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Research Site Us-10001-017
Conway, Arkansas, United States
Research Site Us-10001-008
Newport Beach, California, United States
Research Site Us-10001-022
Northridge, California, United States
Research Site Us-10001-016
Westminster, California, United States
Research Site Us-10001-030
Orlando, Florida, United States
Research Site 10001-032
Champaign, Illinois, United States
Research Site Us-10001-021
Hammond, Indiana, United States
Research Site Us-10001-033
Des Moines, Iowa, United States
Research Site Us-10001-020
Baltimore, Maryland, United States
Research Site Us-10001-024
Farmington Hills, Michigan, United States
Research Site Us-10001-005
Saint Charles, Missouri, United States
Research Site Us-10001-001
St Louis, Missouri, United States
Research Site Us-10001-025
Charlotte, North Carolina, United States
Research Us-10001-010
Charlotte, North Carolina, United States
Research Site Us-10001-007
Gastonia, North Carolina, United States
Research Site Us-10001-004
Columbus, Ohio, United States
Research Site Us-10001-002
DuBois, Pennsylvania, United States
Research Site Us-10001-013
Philadelphia, Pennsylvania, United States
Research Site Us-10001-023
East Providence, Rhode Island, United States
Research Site Us-10001-012
Rock Hill, South Carolina, United States
Research Site Us-10001-009
Corsicana, Texas, United States
Research Site Us-10001-038
Houston, Texas, United States
Research Site 10001-026
McKinney, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 9 Jul 2024
Primary completion: 31 Oct 2025
Completion: 31 Dec 2025
Last update posted: 14 May 2025
Registered enrollment: 30
Registry id: NCT06533553

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.